Schrauwen-Hinderling, VB, Roden, M, Kooi, ME, Hesselink, MKC, Schrauwen, P. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Curr Opin Clin Nutr Met Care, 10, 698-703, 2007.

Paglialunga S, Schrauwen P, Roy C, Moonen-Kornips E, Lu H, Hesselink MK, Deshaies Y, Richard D, Cianflone K. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J Endocrinol, 194 (2), 293-304, 2007.

Mensink M, Hesselink MK, Borghouts LB, Keizer H, Moonen-Kornips E, Schaart G, Blaak EE, Schrauwen P. Skeletal muscle uncoupling protein-3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis? Diabetes Obes Metab, 9 (4), 594-596, 2007.

Schrauwen P. Physical activity and diabetes: current considerations. Appl Physiol Nutr Metab, 32 (3), 535-536, 2007.

Remels AH, Schrauwen P, Broekhuizen R, Willems J, Kersten S, Gosker HR, Schols AM. Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD. Eur Respir J, 30(2), 245-252, 2007.

Schrauwen P. Of the fit and the fat: mitochondrial abnormalities and type 2 diabetes mellitus. J Clin Endocrinol Metab, 92 (4), 1229-1231, 2007.

Schrauwen P. High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc, 66 (1), 33-41, 2007.

Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patient with type 2 diabetes mellitus. Int J Obesity, 31 (8), 1302-1310, 2007.

Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, Jeneson JA, Backes WH, van Echteld CJ, van Engelshoven JM, Mensink M, Schrauen P. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia, 50 (1), 113-120, 2007.